In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation.

导出 OA

翻译打印收藏纠错

作者： Muhammad Hamid,Siddique ^[1] ; Sidra,Bukhari ^[1] ; Inam Ullah,Khan ^[1] ; Asiya,Essa ^[1] ; Zain,Ali ^[1] ; Usama,Sabir ^[1] ; Omiya,Ayoub ^[1] ; Haleema,Saadia ^[1] ; Muhammad,Yaseen ^[2] ; Aneesa,Sultan ^[1] ; Iram,Murtaza ^[1] ; Philip G,Kerr ^[3] ; Mashooq Ahmad,Bhat ^[4] ; Mariam,Anees ^[1]

作者单位： Department of Biochemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan. ^[1] Institute of Chemical Sciences, University of Swat, Charbagh 19130, Pakistan. ^[2] School of Dentistry and Medical Sciences, Charles Sturt University, Sydney, NSW 2678, Australia. ^[3] Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. ^[4]

关键词 MSNPs acute myeloid leukemia caffeine docking doxorubicin nanomedicine

DOI 10.3390/ph16121742

PMID 38139868

发布时间 2023-12-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交